CANbridge Pharmaceuticals Reveals Board Structure
Company Announcements

CANbridge Pharmaceuticals Reveals Board Structure

CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.

CANbridge Pharmaceuticals Inc. has announced its board composition, including Executive Director Dr. James Qun Xue as Chairman and CEO, alongside a list of Non-executive and Independent Non-executive Directors. The company’s board includes three key committees: Audit, Remuneration, and Nomination and Corporate Governance, with various members serving as chairpersons and committee members.

For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App